← Back to Discover
KVP Capital Advisors, LP
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $136,239,482
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $14,362,491
- WHITEHAWK THERAPEUTICS INC · COM · 00032Q104 · shares: $9,920,266
- ERASCA INC · COM · 29479A108 · shares: $8,335,600
- TREVI THERAPEUTICS INC · COM · 89532M101 · shares: $7,721,100
- SUTRO BIOPHARMA INC · COM SHS · 869367201 · shares: $7,522,290
- TANGO THERAPEUTICS INC · COM · 87583X109 · shares: $7,198,053
- MBX BIOSCIENCES INC · COM · 55287L101 · shares: $6,708,125
- PROTAGONIST THERAPEUTICS INC · COM · 74366E102 · shares: $6,496,740
- EDGEWISE THERAPEUTICS INC · COM · 28036F105 · shares: $5,403,790
- TANDEM DIABETES CARE INC · COM NEW · 875372203 · shares: $4,542,090
Reported holdings
35 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 42,900 shares | $14,362,491 |
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | — | 2,165,997 shares | $9,920,266 |
| ERASCA INC | COM | 29479A108 | — | 455,000 shares | $8,335,600 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 414,000 shares | $7,721,100 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 226,575 shares | $7,522,290 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 230,264 shares | $7,198,053 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 121,524 shares | $6,708,125 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 53,000 shares | $6,496,740 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 133,000 shares | $5,403,790 |
| TANDEM DIABETES CARE INC | COM NEW | 875372203 | — | 301,000 shares | $4,542,090 |
| DISC MEDICINE INC | COM | 254604101 | — | 58,250 shares | $4,260,405 |
| SAVARA INC | COM | 805111101 | — | 605,280 shares | $3,728,525 |
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | — | 102,000 shares | $3,543,480 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 28,497 shares | $3,038,350 |
| ACHIEVE LIFE SCIENCES INC | COM | 004468500 | — | 462,355 shares | $3,019,178 |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | — | 79,700 shares | $2,970,419 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 300,000 shares | $2,946,000 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | — | 12,000 shares | $2,937,240 |
| DESIGN THERAPEUTICS INC | COM | 25056L103 | — | 185,000 shares | $2,676,950 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 4,750 shares | $2,573,693 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 45,000 shares | $2,475,000 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 230,423 shares | $2,375,661 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 125,000 shares | $2,296,250 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 84,168 shares | $2,270,853 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 31,813 shares | $2,233,273 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 39,000 shares | $2,215,590 |
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | — | 373,128 shares | $2,201,455 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 200,000 shares | $1,940,000 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 26,900 shares | $1,877,889 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 771,000 shares | $1,688,490 |
| CABALETTA BIO INC | COM | 12674W109 | — | 505,431 shares | $1,571,890 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 32,700 shares | $1,403,157 |
| EVOLUS INC | COM | 30052C107 | — | 150,000 shares | $1,041,000 |
| CELCUITY INC | COM | 15102K100 | — | 4,000 shares | $418,480 |
| VYNE THERAPEUTICS INC | COM | 92941V308 | — | 500,551 shares | $325,709 |